Neratinib
A HER-2 receptor tyrosine kinase inhibitor.
CCOC1=C(C=C2C(=C1)N=CC(=C2NC3=CC(=C(C=C3)OCC4=CC=CC=N4)Cl)C#N)NC(=O)/C=C/CN(C)C
Supporting references
| Link | Tested on | Impact factor | Notes | Publication date |
|---|---|---|---|---|
|
Potential clinical drugs as covalent inhibitors of the priming proteases of the spike protein of SARS-CoV-2
TMPRSS2 Cathepsin B Cathepsin L Small molecule In silico |
in silico | 6.02 | Predicted to inhibit the host cathepsin B and L proteases and thereby inhibit the SAS-CoV-2 entry. |
Aug/26/2020 |
